Transgenomic Inc

Transgenomic Inc. is a global biotechnology company headquartered in Omaha, Nebraska. The company employs 42 people and generates over $10,000 in revenue annually. Transgenomic specializes in advancing personalized medicine through its proprietary molecular technologies and clinical research services. The company provides a range of products and services for cardiology, oncology, and inherited diseases. Their flagship product, the C-GAAP test, is a leading solution for detecting gene mutations associated with cardiac disorders. Transgenomic operates through three distinct divisions: Transgenomic Clinical Laboratories, Transgenomic Pharmacogenomic Services, and Transgenomic Diagnostic Tools. Their clinical laboratories offer molecular diagnostics for various conditions, including cardiology, oncology, neurology, and mitochondrial disorders. Transgenomic Pharmacogenomic Services acts as a contract research laboratory, specializing in supporting oncology drug development trials. Finally, Transgenomic Diagnostic Tools develops and manufactures equipment, reagents, and consumables for molecular testing and cytogenetics applications. To learn more about Transgenomic Inc. and their services, visit their website at www.transgenomic.com.